Swiss National Bank Sells 10,700 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• The Swiss National Bank reduced its stake in Bath & Body Works, Inc. by 2.6%, bringing its total shares to 398,600, valued at approximately $12.1 million.
• Bath & Body Works announced a quarterly dividend of $0.20 per share, which will be paid on September 5th, yielding an annualized rate of 2.8%.
• The stock currently has a market cap of $6.07 billion and a P/E ratio of 7.65, with prominent analysts providing mixed ratings and a consensus target price of $42.19.

Swiss National Bank lowered its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 2.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 398,600 shares of the company's stock after selling 10,700 shares during the quarter. Swiss National Bank owned approximately 0.19% of Bath & Body Works worth $12,086,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of the company. T. Rowe Price Investment Management Inc. boosted its stake in Bath & Body Works by 4.3% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 10,235,086 shares of the company's stock worth $396,815,000 after buying an additional 422,973 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Bath & Body Works by 5.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,494,089 shares of the company's stock worth $329,317,000 after buying an additional 445,887 shares in the last quarter. Victory Capital Management Inc. boosted its stake in Bath & Body Works by 14,732.0% in the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after buying an additional 6,752,274 shares in the last quarter. Anomaly Capital Management LP boosted its stake in Bath & Body Works by 38.3% in the fourth quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company's stock worth $188,456,000 after buying an additional 1,346,752 shares in the last quarter. Finally, D1 Capital Partners L.P. purchased a new stake in Bath & Body Works in the fourth quarter worth approximately $109,797,000. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock traded down $0.1150 during midday trading on Tuesday, reaching $30.0450. 1,139,993 shares of the company's stock traded hands, compared to its average volume of 5,079,919. The company has a market cap of $6.36 billion, a PE ratio of 8.01, a price-to-earnings-growth ratio of 0.96 and a beta of 1.54. The stock has a 50 day moving average of $29.99 and a 200-day moving average of $31.16. Bath & Body Works, Inc. has a 12 month low of $24.94 and a 12 month high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, May 29th. The company reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.47 by $0.02. The company had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The firm's revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.38 earnings per share. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. On average, equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be issued a $0.20 dividend. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.7%. Bath & Body Works's dividend payout ratio is 21.33%.

Analyst Ratings Changes

Several analysts have weighed in on BBWI shares. Piper Sandler set a $39.00 price objective on Bath & Body Works and gave the company an "overweight" rating in a research report on Thursday, May 15th. The Goldman Sachs Group lowered their price objective on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Wells Fargo & Company boosted their price objective on Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research report on Wednesday, May 14th. Barclays lowered their price objective on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a research report on Friday, May 30th. Finally, Citigroup boosted their price objective on Bath & Body Works from $36.00 to $42.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $42.19.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.